Medigus Ltd. announced the appointment of new senior executives and several U.S. regional sales managers. Doron Birger was appointed to the Board of Directors and Jeremy Starkweather was appointed as the new Vice President of U.S. Sales and Marketing. On August 1, 2015 Gilad Mamlok commenced his engagement as Chief Financial Officer.

Doron Birger currently serves as a director of three publicly-traded life sciences companies in Israel (Hadasit Bio-Holdings Ltd., IceCure, and Medical Compression Systems), and as chairman and director of several private companies in the high-technology medical device space. He previously served as director and chairman of the board of Given Imaging, and as Chief Executive Officer of Elron Electronic Industries Ltd., from 2002 until 2009. For all of these innovative, Israeli-based, medical device companies, he has played in a pivotal role in aligning their strategic direction, clinical and commercial planning.

Gilad Mamlok brings over two decades of financial management and business development experience to his new role at Medigus. He previously was at the helm of corporate financial planning, including leading mergers and acquisitions, investor relations and corporate governance, for several public and private medical device and technology companies located in Israel and the U.S. Most recently, he served as Vice President of Finance at Covidien plc, following its acquisition of Given Imaging, where he was Senior Vice President, Global Finance and Accounting since 2005.